查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722989

2025 年至 2033 年糖組學市場規模、佔有率、趨勢及預測（按產品、應用、最終用戶和地區）

Glycomics Market Size, Share, Trends and Forecast by Product, Application, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 134 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球糖組學市場規模價值 17 億美元。展望未來， IMARC Group估計到 2033 年市場規模將達到 45 億美元，2025 年至 2033 年的複合年成長率為 10.61%。北美目前佔據市場主導地位，2024 年的市佔率將超過 39.1%。由於慢性病發病率的上升、對糖工程技術的關注度的提高以及參與藥物和生物製劑的合約研究組織 (CRO) 數量的增加，糖組學市場佔有率正在上升。

糖組學是一門專注於全面研究生物系統中的碳水化合物，特別是聚醣的科學領域。其目的是了解聚醣的結構、組成和功能，以及它們與其他生物分子的相互作用。透過分析醣組，研究人員可以確定聚醣如何影響生物過程並導致健康和疾病。這個跨學科領域結合了化學、生物化學、分子生物學和資訊學的各個方面，以揭示聚醣結構和功能的複雜性。研究獲得的見解對醫學、藥物開發、生物標記發現和個人化治療等各個領域都有影響。

全球市場主要受到慢性病日益普及的推動。此外，由於糖工程涉及對聚醣的修飾或操縱，以用於各種應用，包括治療、疫苗和生物技術，因此對糖工程的日益關注正在支撐市場。除此之外，各國政府、研究機構和私人投資者都認知到糖組學在推動醫療保健和生物技術方面的潛力，並提供投資進行深入研究、開發新技術、探索基於糖組學的產品商業化，從而推動市場發展。此外，它在世界各地的教育和培訓領域越來越受歡迎。此外，參與藥物和生物製劑開發和生產的合約研究組織（CRO）數量的不斷成長也促進了市場的成長。其他因素，如製藥業的擴張、臨床試驗數量的增加以及醫療保健基礎設施的進步，也正在影響市場。

糖組學市場趨勢/促進因素：

增加研發活動

市場正在經歷研發活動的顯著成長。隨著對聚醣在各種生物過程中所扮演的關鍵角色的了解不斷加深，人們對研究和操縱這些分子的興趣也日益增加。研究人員和製藥公司正在投資研究，探索聚醣在藥物發現、個人化醫療和診斷方面的潛在應用。此外，分析技術和技術的不斷進步也推動著研究範圍的不斷擴大。此外，學術界、產業界和研究機構之間的合作推動了糖組學研發的發展。這些合作匯集了不同的專業知識和資源，促進了創新並加速了基於糖組學的產品的開發。此外，各利害關係人之間的協作努力有助於擴展知識、開發新技術以及將研究成果轉化為實際應用。

個人化醫療需求不斷成長

個人化醫療正日益受到重視，其目的是根據患者的基因組成和具體特徵為其量身定做醫療方案。它在個人化醫療中發揮關鍵作用，因為聚醣與各種疾病有關，並且可以作為診斷和預後的潛在生物標記。分析和了解患者的血糖水平的能力有助於開發有針對性的治療方法和更精準的醫療干預措施。此外，糖組學分析技術（如糖微陣列和糖測序）的進步促進了疾病特異性糖特徵的識別。這些發現為基於聚醣的診斷、個人化治療和伴隨診斷的發展帶來了希望，進一步推動了對糖組學研究和產品的需求。

日益關注生物標記的發現

糖組學在生物標記發現領域引起了廣泛關注。聚醣已顯示出作為各種疾病（包括癌症、心血管疾病和傳染病）的生物標記的巨大潛力。生物標記在疾病診斷、預後和監測治療效果中發揮著至關重要的作用。此外，人們對生物標記發現的日益關注推動了研究的需求，因為識別可靠和特定的生物標記對於改善疾病檢測、患者分層和治療選擇至關重要。此外，將糖組學整合到生物標記發現流程中，有可能徹底改變診斷方式並實現早期干預，從而推動整個市場的成長。此外，該研究還提供了一個獨特的機會來識別與不同疾病相關的特定聚醣模式或變化。透過研究個體或患者群體的醣組，研究人員可以揭示可作為診斷或預後生物標記的疾病特異性聚醣特徵。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球糖組學市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 酵素
    • 關鍵部分
      • 糖苷酶
      • 糖基轉移酶
      • 神經氨酸酶
      • 唾液酸轉移酶
      • 其他
  • 儀器
    • 關鍵部分
      • 質譜儀
      • 高效液相層析
      • 基質輔助雷射解吸電離飛行時間質譜法
      • 陣列系統
      • 其他
  • 套件
    • 關鍵部分
      • 聚醣標記試劑盒
      • 聚醣純化試劑盒
      • 聚醣釋放試劑盒
      • 其他
  • 試劑
    • 關鍵部分
      • 糖蛋白
      • 單醣
      • 寡糖
      • 其他

第7章：市場區隔：依應用

  • 藥物研發
  • 診斷
  • 其他

第8章：市場區隔：按最終用戶

  • 學術和研究機構
  • 製藥和生物技術公司
  • 合約研究組織（CRO）

第9章：市場細分：依地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第10章：SWOT分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：價值鏈分析

第 12 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第13章：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Agilent Technologies Inc.
    • Asparia Glycomics
    • Bruker Corporation
    • Danaher Corporation
    • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
    • Merck KGaA
    • New England Biolabs
    • RayBiotech Life Inc.
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112025A5689

The global glycomics market size was valued at USD 1.7 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 4.5 Billion by 2033, exhibiting a CAGR of 10.61% from 2025-2033. North America currently dominates the market, holding a market share of over 39.1% in 2024. The glycomics market share is rising due to the growing incidence of chronic diseases, rising focus on glycoengineering techniques, and increasing number of contract research organizations (CROs) involved in drug and biologics.

Glycomics is a scientific field that focuses on the comprehensive study of carbohydrates, specifically glycans, in biological systems. It aims to understand the structure, composition, and functions of glycans, as well as their interactions with other biomolecules. By analyzing the glycome, researchers can determine how glycans influence biological processes and contribute to health and disease. This interdisciplinary field combines aspects of chemistry, biochemistry, molecular biology, and informatics to unravel the complexities of glycan structures and functions. The insights gained from the research have implications across various domains, including medicine, drug development, biomarker discovery, and personalized therapeutics.

The global market is primarily driven by the growing prevalence of chronic diseases. Moreover, the increasing focus on glycoengineering is supporting the market as glycoengineering involves the modification or manipulation of glycans for various applications, including therapeutics, vaccines, and biotechnology. Apart from this, Governments, research organizations, and private investors are recognizing the potential of glycomics in advancing healthcare and biotechnology and are providing investments to conduct in-depth studies, develop new technologies, and explore the commercialization of glycomics-based products, providing a boost to the market. Furthermore, it is gaining popularity in the field of education and training worldwide. Additionally, the growing number of contract research organizations (CROs) involved in drug and biologics development and production is augmenting the market growth. Other factors, such as expanding pharmaceutical industry, increasing number of clinical trials, and advancements in healthcare infrastructure, are also influencing the market.

Glycomics Market Trends/Drivers:

Increasing Research and Development Activities

The market is experiencing a significant boost in research and development (R&D) activities. The growing understanding of the crucial roles played by glycans in various biological processes has increased interest in studying and manipulating these molecules. Researchers and pharmaceutical companies are investing in research to explore the potential applications of glycans in drug discovery, personalized medicine, and diagnostics. Moreover, the expanding scope of the research is driven by continuous advancements in analytical techniques and technologies. Furthermore, collaborations between academia, industry, and research institutions have fueled the growth of glycomics R&D. These collaborations bring together diverse expertise and resources, fostering innovation and accelerating the development of glycomics-based products. Additionally, the collaborative efforts between various stakeholders contribute to the expansion of knowledge, development of new technologies, and translation of research findings into practical applications.

Rising Demand for Personalized Medicine

Personalized medicine, which aims to tailor medical treatments to individual patients based on their genetic makeup and specific characteristics, is gaining prominence. It plays a pivotal role in personalized medicine as glycans have been implicated in various diseases and can serve as potential biomarkers for diagnostics and prognostics. The ability to analyze and understand the glycome of patients can enable the development of targeted therapies and more precise medical interventions. In addition, the advancements in glycomics profiling technologies, such as glycan microarrays and glycan sequencing, have facilitated the identification of disease-specific glycan signatures. These discoveries hold promise for the development of glycan-based diagnostics, personalized therapeutics, and companion diagnostics, further fueling the demand for glycomics research and products.

Increasing Focus on Biomarker Discovery

Glycomics has gained significant attention in the field of biomarker discovery. Glycans have shown promising potential as biomarkers for various diseases, including cancer, cardiovascular disorders, and infectious diseases. Biomarkers play a crucial role in disease diagnosis, prognosis, and monitoring treatment efficacy. Moreover, the growing focus on biomarker discovery has propelled the demand for research, as the identification of reliable and specific biomarkers is crucial for improving disease detection, patient stratification, and treatment selection. Furthermore, the integration of glycomics into biomarker discovery pipelines has the potential to revolutionize diagnostics and enable early intervention, driving the growth of the overall market. Also, the research offers a unique opportunity to identify specific glycan patterns or alterations associated with different diseases. By studying the glycome of individuals or patient cohorts, researchers can unveil disease-specific glycan signatures that can serve as diagnostic or prognostic biomarkers.

Glycomics Industry Segmentation:

Breakup by Product:

  • Enzymes
  • Glycosidases
  • Glycosyltransferases
  • Neuraminidases
  • Sialyltransferases
  • Others
  • Instruments
  • Mass Spectrometers
  • HPLC
  • MALDI-TOF
  • Array systems
  • Others
  • Kits
  • Glycan Labeling Kits
  • Glycan Purification Kits
  • Glycan Release Kits
  • Others
  • Reagents
  • Glycoproteins
  • Monosaccharides
  • Oligosaccharides
  • Others

Enzymes equipment dominates the market

On the basis of the product, enzymes represent the largest product segment within the market. Enzymes play a crucial role in research and applications by facilitating the analysis and manipulation of glycans. Enzymes, such as glycosidases, glycosyltransferases, and glycosyl hydrolases, are utilized in various workflows, including glycan release, structural analysis, and glycan modification. Moreover, enzymes are essential for the enzymatic cleavage of glycans from glycoproteins or glycolipids, enabling the analysis of liberated glycans. The demand for enzymes in research and applications is driven by the growing need for robust and efficient enzymatic tools. Researchers and scientists rely on enzymes to accurately and selectively manipulate glycans, enabling comprehensive glycomics analysis and the development of glycan-based products. Additionally, advancements in enzyme engineering and optimization have led to the development of highly specific and efficient enzymes, further enhancing their utility in glycomics research.

Breakup by Application:

  • Drug Discovery and Development
  • Diagnostics
  • Others

Drug discovery and development hold the largest share in the market

On the basis of application, drug discovery and development represent the largest segment within the overall market. It plays a crucial role in advancing drug discovery and development processes by providing insights into the role of glycans in disease mechanisms, drug efficacy, and safety. Glycans are involved in various biological processes and have been linked to numerous diseases, including cancer, cardiovascular disorders, and infectious diseases. Understanding the glycan profiles and their interactions with proteins and cells is essential for identifying potential therapeutic targets and designing effective drugs. Moreover, the integration with drug discovery and development processes has led to the development of glycan-based therapies, companion diagnostics, and improved drug screening platforms. Also, the focus on targeting glycans in drug discovery and development has driven the demand for research and technologies, making it the largest application segment within the market.

Breakup by End User:

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)

Academic and research institutes hold the largest share in the market

Academic and research institutes represent the largest segment of the market. They play a vital role in driving research and advancements in the field. These institutions serve as the primary hubs for scientific research, knowledge generation, and innovation in the field. They are home to leading scientists, researchers, and experts who are actively involved in studying and exploring the complexities of glycans. These institutions also provide the necessary infrastructure, funding, and collaborative opportunities to support the research. They often house state-of-the-art laboratories equipped with advanced analytical instruments and technologies, enabling comprehensive glycan analysis and profiling. Furthermore, academic and research institutes contribute significantly to expanding the knowledge base through publications, scientific conferences, and collaborations. They foster interdisciplinary research collaborations, bringing together experts from various fields such as chemistry, biology, bioinformatics, and medicine.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance, accounting for the largest glycomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America accounted for the largest market share.

Region-wise, North America exhibits a clear dominance in the market. North America is home to several renowned academic institutions, research organizations, and biotechnology companies that have made significant contributions to the research. These institutions have robust research infrastructure, state-of-the-art laboratories, and well-established collaborations, facilitating cutting-edge studies and innovation. Moreover, the region has a well-developed healthcare and biopharmaceutical sector, which drives the demand for research and applications. The presence of major pharmaceutical companies and biotech firms in North America leads to significant investments in the research for drug discovery, personalized medicine, and the development of glycan-based therapeutics. Furthermore, the region has a favorable regulatory environment and strong intellectual property protections that encourage innovation and commercialization of glycomics-based products. The region's well-defined regulatory frameworks provide clarity and guidance for research, ensuring the safety and efficacy of glycan-based diagnostics and therapeutics.

Competitive Landscape:

Companies in the market are involved in various activities related to glycomics research, product development, and commercialization. Several major companies are investing in research and development to advance the understanding of glycans, develop new technologies, and explore applications in various fields. They conduct studies to uncover the roles of glycans in disease mechanisms, identify glycan biomarkers, and understand glycan-protein interactions. Moreover, the companies in the market develop and manufacture products that support the research. This includes enzymes, kits, reagents, and instruments used in glycan analysis, glycan profiling, and glycan modification. These products help researchers in academia, pharmaceutical companies, and research institutes carry out glycomics experiments and investigations. Additionally, some companies focus on translating research into commercial applications. They develop and market glycan-based products for various industries, such as biopharmaceuticals, diagnostics, and nutraceuticals.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Agilent Technologies Inc.
  • Asparia Glycomics
  • Bruker Corporation
  • Danaher Corporation
  • Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
  • Merck KGaA
  • New England Biolabs
  • RayBiotech Life Inc.
  • Shimadzu Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • Waters Corporation.

Recent Developments:

In June 2023, Agilent Technologies Inc. launched Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities. The BioTek 406 FX offers expanded liquid handling features designed for integration into automated systems and standalone benchtop use.

In March 2023, Waters Corporation launched Next-Generation Alliance iS HPLC System aimed at reducing Up to 40% of Common Lab Errors. This new product helps laboratories manage operational risk, mitigate disruptions, and increase overall productivity.

In September 2022, Thermo Fisher Scientific Inc. launched the DynaSpin(TM) Single-Use Centrifuge system2. The system is specifically designed to provide an optimal single-use solution for large-scale cell culture harvesting. It also improves and streamlines harvesting for cell culture separation in single-use bioprocesses by reducing the number of depth filtration cartridges required to complete the harvest process.

Key Questions Answered in This Report

  • 1.How big is the glycomics market?
  • 2.What is the future outlook of glycomics market?
  • 3.What are the key factors driving the glycomics market?
  • 4.Which region accounts for the largest glycomics market share?
  • 5.Which are the leading companies in the global glycomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Glycomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Enzymes
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Glycosidases
      • 6.1.2.2 Glycosyltransferases
      • 6.1.2.3 Neuraminidases
      • 6.1.2.4 Sialyltransferases
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Mass Spectrometers
      • 6.2.2.2 HPLC
      • 6.2.2.3 MALDI-TOF
      • 6.2.2.4 Array systems
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast
  • 6.3 Kits
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Glycan Labeling Kits
      • 6.3.2.2 Glycan Purification Kits
      • 6.3.2.3 Glycan Release Kits
      • 6.3.2.4 Others
    • 6.3.3 Market Forecast
  • 6.4 Reagents
    • 6.4.1 Market Trends
    • 6.4.2 Key Segments
      • 6.4.2.1 Glycoproteins
      • 6.4.2.2 Monosaccharides
      • 6.4.2.3 Oligosaccharides
      • 6.4.2.4 Others
    • 6.4.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Drug Discovery and Development
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Diagnostics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Others
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Academic and Research Institutes
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Pharmaceutical and Biotechnology Companies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Contract Research Organizations (CROs)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Agilent Technologies Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Asparia Glycomics
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bruker Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Danaher Corporation
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Dextra Laboratories Limited (New Zealand Pharmaceuticals Limited)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Merck KGaA
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 New England Biolabs
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 RayBiotech Life Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Shimadzu Corporation
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Takara Bio Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
    • 14.3.11 Thermo Fisher Scientific Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Waters Corporation
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Glycomics Market: Major Drivers and Challenges
  • Figure 2: Global: Glycomics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Glycomics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Glycomics Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Glycomics Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Glycomics Market: Breakup by End User (in %), 2024
  • Figure 7: Global: Glycomics Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Glycomics (Enzymes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Glycomics (Enzymes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Glycomics (Instruments) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Glycomics (Instruments) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Glycomics (Kits) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Glycomics (Kits) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Glycomics (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Glycomics (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Glycomics (Drug Discovery and Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Glycomics (Drug Discovery and Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Glycomics (Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Glycomics (Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Glycomics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Glycomics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Glycomics (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Glycomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Glycomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Glycomics (Contract Research Organizations-CROs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Glycomics (Contract Research Organizations-CROs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: North America: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: North America: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: United States: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: United States: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Canada: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Canada: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Asia-Pacific: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Asia-Pacific: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: China: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: China: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Japan: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Japan: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: India: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: India: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: South Korea: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: South Korea: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Australia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Australia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Indonesia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Indonesia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Europe: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Europe: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Germany: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Germany: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: France: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: France: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: United Kingdom: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: United Kingdom: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Italy: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Italy: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Spain: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Spain: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Russia: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Russia: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Latin America: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Latin America: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Brazil: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Brazil: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Mexico: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Mexico: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Others: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Others: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Middle East and Africa: Glycomics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Middle East and Africa: Glycomics Market: Breakup by Country (in %), 2024
  • Figure 76: Middle East and Africa: Glycomics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Global: Glycomics Industry: SWOT Analysis
  • Figure 78: Global: Glycomics Industry: Value Chain Analysis
  • Figure 79: Global: Glycomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Glycomics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Glycomics Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Glycomics Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Glycomics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 5: Global: Glycomics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Glycomics Market: Competitive Structure
  • Table 7: Global: Glycomics Market: Key Players